Dispase: Properties, Preparation, and Application Workflows of a Basement-Membrane-Loosening Tissue Dissociation Protease

Dispase is a class of neutral protease preparations widely used for cell and tissue dissociation. Its core utility is to preferentially weaken adhesion networks mediated by basement-membrane and extracellular matrix (extracellular matrix, ECM) proteins under relatively mild proteolytic conditions, thereby enabling tissue-sheet delamination, dissociation of tissue fragments, and dispersion of cell aggregates. Compared with proteases with broader cleavage profiles such as trypsin, dispase emphasizes adhesion loosening rather than exhaustive digestion, and is therefore often more favorable for maintaining plasma-membrane integrity and reducing the risk of cleaving cell-surface receptors and antigens. As a result, it is advantageous in applications that demand high phenotype fidelity, including epithelial separation, organoid culture, and immunophenotyping.

Keywords: dispase; Dispase; metalloprotease; Zn2+; Ca2+-stabilized; Paenibacillus; submerged fermentation; chromatographic purification; animal-origin-free; tissue dissociation; epithelial delamination; organoids; single-cell sequencing

I. Basic Concepts and Reagent Attributes

1.1 Definition and Naming Considerations

(1) Functional definition

Dispase refers to a class of neutral protease preparations used for tissue and cell dissociation, characterized by promoting cell–matrix adhesion loosening under mild conditions. It is commonly used for delamination, separation, and gentle dispersion, rather than for complete digestion.

(2) Formulation attributes and lot-to-lot variability

Dispase is often supplied as an off-white to yellow-brown powder and is readily soluble in water. Different sources and lots may differ in unit activity, background contaminating proteins, and stability. Methodologically, lot consistency is best managed using activity units and functional outputs (viability, yield, size distribution, marker retention), rather than equating lots solely by mass concentration.

1.2 Physicochemical Parameters and Metalloprotease Features

(1) Molecular weight and isoelectric point

Dispase typically has a molecular weight of ~35–40 kDa (commonly ~36 kDa) and an isoelectric point of ~8–9.

(2) Metalloprotease nature and ion dependence

Dispase is a metalloprotease: its active site contains Zn2+, and Ca2+ often stabilizes the active conformation. Accordingly, chelators (EDTA, EGTA) can strongly inhibit activity, whereas divalent cations (Ca2+, Mg2+, Mn2+, Fe2+, etc.) may enhance or stabilize activity under certain conditions.

(3) pH and temperature windows

Dispase is generally stable across pH 4.0–9.0, with higher stability often observed around pH 5.5–8.5; reported optimal pH is commonly near 6.8–7.0. Reported optimal temperature is often 45–50°C, and the enzyme is typically sufficiently stable under standard 37°C cell-culture conditions.

II. Production and Formulation: From Fermentation Supernatant to a Controlled Enzyme Preparation

2.1 Origin and Production Strains

(1) Source lineage

Dispase is mainly derived from bacteria, with production strains commonly associated with Paenibacillus species (Paenibacillus sp.; formerly referred to as Bacillus polymyxa).

(2) Process advantages of extracellular secretion

Dispase is often secreted into the fermentation broth, enabling removal of cells by clarification, reducing the burden of intracellular proteins released by lysis, and limiting impurity-profile variability.

2.2 Key Control Points in Submerged Fermentation

(1) Seed train and scale-up consistency

① Establish a staged seed train and control inoculum age and inoculation ratio to reduce batch-to-batch differences in yield and protein profile.

② Monitor contamination and pre-screen activity in production seed cultures to prevent hidden contamination from driving impurity anomalies.

(2) Fermentation process control

① Aeration and agitation: control dissolved oxygen and shear environment to maintain stable growth and secretion.

② Temperature and pH: closed-loop control within suitable ranges to reduce protein degradation and mitigate induction of unwanted proteases.

③ Nutrition and feeding: apply feeding strategies to balance growth and secretion, avoiding substrate inhibition and accumulation of metabolic byproducts.

(3) Harvest window and activity preservation

① Define the harvest window based on an activity-versus-time curve to avoid entering autolysis phases that elevate contaminating proteins.

② After harvest, promptly clarify and process at low temperature to reduce activity loss and impurity increases caused by spontaneous proteolysis.

2.3 Clarification, Concentration, and Preparation of Crude Enzyme Powder

(1) Clarification and cell removal

① Use centrifugation or membrane filtration to remove cells and suspended solids, yielding an enzyme-containing supernatant.

② For workflows with stricter particulate and bioburden requirements, cascade filtration can further reduce residual particulates.

(2) Concentration and preliminary impurity reduction

① Salting-out concentration: enrich the target protein from the supernatant, reduce volume, and remove a portion of soluble impurities.

② Desalting/buffer exchange: dialysis or equivalent processes remove excess salt and exchange into the target buffer, improving reconstitution behavior and cell compatibility.

(3) Drying and powder formation

① Lyophilization or spray drying can generate solid formulations; lyophilization better preserves activity, whereas spray drying is often more scalable.

② Milling and sieving can improve particle-size uniformity, enhancing reconstitution consistency and weighing accuracy.

(4) Applicability boundary of crude powder

Crude enzyme powders are suitable for workflows with higher tolerance for contaminating proteins; for applications highly sensitive to surface antigens or downstream function, higher-purity preparations are preferred.

2.4 Obtaining High-Purity Preparations and Purification Routes

(1) Purification objectives

① Reduce non-target protease activities and contaminating protein background to minimize non-specific proteolysis.

② Improve inter-lot comparability by stabilizing the relationship between unit activity and practical dissociation outcomes.

(2) Common purification strategy frameworks

① Ion-exchange chromatography: enrich based on charge differences while removing a portion of impurities.

② Size-exclusion chromatography: further purify by molecular size and remove aggregates.

③ Hydrophobic interaction or other combined strategies: strengthen purity and improve impurity profiles.

(3) Quality attributes after purification

① Specific activity (U/mg) and activity recovery.

② Impurity profile and residual non-target protease levels.

③ Endotoxin and microbiological limits (defined according to the intended use scenario).

2.5 Formulation Versions and Compliance-Relevant Attributes

(1) Animal-origin-free (AOF) versions

For cell therapy, regenerative medicine, and GMP-leaning workflows, AOF versions reduce risks associated with animal-derived components and can simplify raw-material compliance review.

(2) Process implications of termination strategy

Dispase is often not strongly inhibited by serum, so termination should rely more on chelation/dilution/washing rather than serum quenching, to avoid residual activity persisting during subsequent culture.

III. Reagent Use, Storage, and Termination Strategies

3.1 Working-Solution Preparation and Storage

(1) Preparation considerations

Prepare in sterile buffer and, when needed, sterile-filter; avoid prolonged room-temperature exposure and repeated freeze–thaw cycles.

(2) Stability management

Dispase solutions are often usable for ~2 weeks at 4°C and ~2 months at -20°C under typical handling; aliquoting by single-use volume is recommended to avoid freeze–thaw cycling.

3.2 Controllable Paths for Termination and Inactivation

(1) Chelator inhibition/inactivation

EDTA or EGTA reduces effective activity by chelating divalent metal ions and can serve as a rapid inhibition approach.

(2) Termination by dilution and washing

Large-volume dilution lowers effective enzyme concentration, and centrifugation/washing removes residual enzyme, reducing the risk of continued digestion in downstream steps.

(3) Combination principle

For workflows sensitive to surface antigens or requiring long-term culture, combining chelation with dilution-and-washing improves termination certainty.

IV. Representative Process Scenarios and Control of Output Morphology

4.1 Epithelial Delamination and Basement-Membrane-Related Tissue Separation

(1) Skin, corneal, and mucosal epithelial separation

① Target outputs include continuous epithelial sheets or high-integrity epithelial cell aggregates.

② Use a mild, time-bounded window to loosen the basement membrane and minimize harsh shear; use tissue-sheet integrity and viability as release criteria.

③ Downstream applications include epithelial barrier models, keratinocyte culture, immunophenotyping, and preparation of tissue-engineering precursors.

(2) Tiered handling after epithelial–stromal separation

① Epithelial sheets can be further gently dispersed into aggregates or single cells depending on the need to preserve cell–cell junctions.

② Residual stromal tissue can be processed with collagenase-based strategies to recover stromal cells, enabling differentiated handling after layer separation.

4.2 Enrichment of Glandular/Ductal Structures and Preparation of Organoid Starting Materials

(1) Enrichment logic

Dispase loosens basement-membrane adhesion surrounding ducts/glands, increasing the probability of releasing epithelial structures from the matrix.

(2) Tiered strategy prioritizing structure retention

① Use mesh filtration to retain duct- or gland-like structures or epithelial aggregates within a target size range.

② Use sedimentation or low-speed centrifugation to remove debris and excess single-cell background, improving structural purity of starting material.

(3) Consistency control for initiation culture

Use process indicators such as structure count per unit tissue, size distribution, initial aggregation rate, or budding rate to improve inter-batch comparability and traceability.

4.3 Release, Dispersion, and Matrix Removal for 3D-Culture-Related Structures

(1) Releasing structures from matrices

Dispase can reduce matrix adhesion and facilitate release of organoids or other 3D structures, reducing death and structural damage caused by aggressive mechanical disruption.

(2) Passage-size control

Combine limited digestion with gentle mechanical dispersion to constrain aggregate size into a window suitable for regrowth, avoiding excessive single-cell dissociation.

(3) Coupling to downstream analyses

For imaging, spatial omics, or drug-response assessments, processing often aims to reduce matrix background while maintaining structural integrity, improving interpretability of readouts.

4.4 Product Fractionation and Modular Single-Cell Generation Workflows

(1) Goals of fractionation

① Fractionate dissociation outputs by size for epithelial-sheet culture, organoid initiation, single-cell analyses, or cell banking.

② Reduce debris and dead-cell fractions to improve effective inputs for sorting, sequencing, or culture.

(2) Modular path to single-cell suspension

① Pre-loosening: use dispase to reduce basement-membrane adhesion, lowering the mechanical force required for subsequent dispersion.

② Low-shear dispersion: apply gentle mechanical dispersion to control injury and stress.

③ Fine fractionation: use filtration and centrifugation to control aggregation and doublet rates.

(3) Termination and residual-enzyme control

① Apply chelation and dilution to suppress activity.

② Wash to remove residual enzyme, preventing continued digestion during subsequent culture or staining.

4.5 Cooperative Digestion Strategies for Complex Tissues

(1) Staged cooperation with collagenase

① For collagen-rich or fibrotic tissues, use collagenase first to reduce stromal resistance, then apply dispase to loosen basement-membrane adhesion, improving yield and reducing the need for harsh shear.

② Staged cooperation separates stromal degradation from basement-membrane loosening, reducing phenotype damage caused by one-step aggressive digestion.

(2) Coupling with a nuclease module

Cell lysis increases free DNA, raising viscosity and reducing filtration efficiency; moderate inclusion of a nuclease module can sustain throughput and reproducibility and reduce aggregation and filter clogging.

V. Research Applications: Experimental Design, Readouts, and Reproducibility Control

5.1 Immunophenotyping, Membrane-Receptor Studies, and Flow Sorting

(1) Suitable question types

① Maximize preservation of membrane receptors, adhesion molecules, or epitopes for phenotyping, sorting, and receptor function assessment.

② Reduce epitope cleavage and false negatives caused by broad-spectrum proteases.

③ Achieve a controllable trade-off between dissociation efficiency and phenotype fidelity.

(2) Evidence chain and release criteria

① Compare positivity rate, MFI, and cluster boundary stability for key antigens before and after digestion.

② Use time gradients to define the shortest effective digestion window and lock it as a standard condition.

③ Include process controls for same-lot, same-origin samples to monitor within-batch drift and operator variability.

5.2 Sample Preprocessing for Single-Cell Sequencing and Spatial Omics

(1) Gentle dissociation prior to single-cell sequencing

① Use dispase as a pre-loosening module to reduce basement-membrane adhesion, followed by low-shear dispersion, reducing debris and the risk of stress-associated transcriptional artifacts.

② For high-ECM or fibrotic samples, staged cooperative digestion can better mitigate stress shifts induced by one-step aggressive digestion.

(2) Structural handling prior to spatial omics and imaging

① When layered architecture or relatively intact tissue units must be preserved, dispase can be used for interface loosening to enable controlled delamination.

② Use structural integrity, viability, and retention of target markers as process metrics, rather than using release quantity alone.

5.3 Organoid Initiation, Passaging, and Drug-Response Studies

(1) Obtaining starting materials and improving consistency

① Loosen basement-membrane adhesion around ducts/glands and pair with size fractionation to enrich structural starting materials, improving initiation consistency.

② Control size distributions to reduce structural heterogeneity and improve between-group comparability.

(2) Consistency control for passaging and experimental handling

① Use aggregate-size windows as passaging control indices to avoid excessive single-cell conversion that can impose selection pressure and drive differentiation shifts.

② In drug-response or differentiation-induction studies, fix and record dissociation conditions as key variables to avoid them becoming hidden confounders.

5.4 Mechanistic Studies of Matrix Dependence and Cooperative Digestion

(1) Research logic for cooperative design

① Collagen-rich samples: use collagenase to reduce stromal resistance, then dispase to loosen basement-membrane adhesion.

② High-viscosity DNA-rich samples: introduce a nuclease module to improve filtration and sorting performance.

③ Antigen-sensitive samples: prioritize short dispase windows and strengthen termination and washing to reduce receptor cleavage.

(2) Control points for comparative experiments

① Use output per unit tissue mass/volume as one normalization basis.

② Record tissue-fragment size, temperature, time, pipetting strokes, and filter specifications as reproducibility conditions.

③ Use the same enzyme lot for key comparisons to prevent lot variability from obscuring true matrix effects.

VI. Quality Control and Release Criteria

6.1 Output Metric System

① Total yield and output per unit tissue.

② Viability and early apoptosis fraction.

③ Single-cell fraction or aggregate size distribution.

④ Retention of key surface markers (pre/post digestion differential).

⑤ Debris fraction, aggregation level, and background-signal level.

6.2 Controls and Bias Localization

① No-enzyme control: defines the mechanical-separation baseline.

② Time-gradient control: identifies over-digestion inflection points and the linear release window.

③ Lot control: compares output consistency across lots using the same tissue/cell source.

VII. Aladdin-Related Products

7.1 Dispase Product List (Type I and Type II Preparations)

Catalog No.	Product Name	Grade and Purity
D743370	Dispase II	EnzymoPure™, ≥0.5 units/mg
D1516119	Dispase I	Animal Free, Bioactive, ActiBioPure™, Native, High Performance, Mycoplasma free, EnzymoPure™, sterile, from Paenibacillus polymyxa; 10,000–13,000 PU/vial
D1516122	Dispase II	Animal Free, Bioactive, ActiBioPure™, Native, High Performance, Mycoplasma free, EnzymoPure™, from Paenibacillus polymyxa; 300-360 PU/mg enzyme powder

7.2 Key Reagents Commonly Used in Dispase-Related Tissue Dissociation Workflows

Name	CAS No.	Use Stage	Role in the Workflow	Handling Notes
EDTA disodium salt	6381-92-6	Termination/inhibition	Chelates divalent cations to inhibit metalloprotease activity for rapid termination of Dispase reactions	Termination should be immediate and thoroughly mixed; if downstream steps require Ca2+/Mg2+, wash to remove chelator or re-supplement ions
EGTA	67-42-5	Termination/inhibition (optional)	Preferentially chelates Ca2+ to inhibit Ca2+-stabilized activity or refine termination strategy	Different selectivity vs EDTA; fix final concentration and validate “residual activity after termination”
Calcium chloride (CaCl2)	10043-52-4	Reaction stabilization (optional)	Supplies Ca2+ to stabilize metalloprotease conformation and support stable activity expression (as needed)	Mutually exclusive with EDTA/EGTA; verify compatibility and phenotype impacts in the target tissue/cells before use
Magnesium chloride (MgCl2)	7786-30-3	Ionic environment control (optional)	Adjusts ionic strength and provides divalent cations for certain auxiliary modules (e.g., nucleases)	Fix final Mg2+ concentration; avoid co-presence with chelators in the same system to prevent condition drift
Collagenase A	9001-12-1	Cooperative digestion (staged/combined)	Reduces collagen matrix resistance first, then Dispase preferentially loosens basement-membrane adhesion to improve release and recovery	Use time gradients to define the shortest effective window; for antigen-sensitive workflows, prioritize staged short treatments
Collagenase II	9001-12-1	Cooperative digestion (staged/combined)	Implements a “stroma–basement membrane” division-of-labor strategy with Dispase for collagen-rich tissues	Large lot variability; prepare by activity units and perform cross-lot bridging calibration
DNase I	9003-98-9	Throughput control/viscosity reduction	Degrades free DNA to reduce viscosity after lysis, improving filtration and sorting and reducing aggregation	Requires Mg2+/Ca2+ for activity; remove residual nuclease by EDTA or washing to avoid impacting downstream nucleic-acid steps
BSA (bovine serum albumin)	9048-46-8	Carrier/stabilizer and non-specific adsorption control	Reduces non-specific adsorption of enzymes/cells to tubes and filters, improving recovery and consistency	Match vehicle controls; use low-endotoxin grade and fix lot and concentration
Triton X-100	9002-93-1	Lysis/washing (as needed)	Used for lysis or washing in certain workflows (e.g., preparing lysates for protein assays)	Generally not recommended during tissue dissociation; if used, pre-validate effects on viability and surface markers
Tween 20	9005-64-5	Washing/background control (as needed)	Reduces non-specific adhesion and clumping to improve washing consistency (workflow-dependent)	Excess concentration may affect membranes and downstream labeling; fix final concentration and include controls

Dispase is a neutral metalloprotease preparation produced via submerged bacterial fermentation and commonly obtained as an extracellularly secreted product. Industrially, it can be manufactured as a crude enzyme powder through salting-out concentration, desalting/buffer exchange, and drying, and higher-purity preparations with lower contaminating protease background can be achieved via chromatographic purification; for compliance-sensitive workflows, animal-origin-free versions may be selected to mitigate risks associated with animal-derived materials. Dispase has clear tool value in epithelial delamination, dissociation of tissue fragments, enrichment of glandular/ductal structures, release and passaging of 3D structures, and antigen-preserving single-cell generation workflows. In research settings, combining marker-retention validation, time-gradient window definition, and process-control design supports immunophenotyping, single-cell sequencing, spatial omics, and mechanistic studies of matrix dependence with reproducible inputs and interpretable readouts.

For more related articles, please see below:

[1] Rat brain microvascular endothelial cell primary culture experiment